Covestor’s Lifecore Biomedical LFCR Stock Holding History

Covestor’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$66K	Buy	9,961 +1,648	+20%	+$7.64K	0.04%	593
2026 Q2	$44K	Hold	8,313	–	–	0.03%	862
2026 Q1	$31K	Sell	8,313 -34	-0.4%	-$235	0.02%	940
2025 Q4	$68K	Buy	8,347 +944	+13%	+$6.98K	0.04%	777
2025 Q3	$54K	Sell	7,403 -8	-0.1%	-$61	0.03%	871
2025 Q2	$60K	Buy	7,411 +569	+8%	+$3.84K	0.04%	822
2025 Q1	$48K	Hold	6,842	–	–	0.03%	864
2024 Q4	$51K	Hold	6,842	–	–	0.03%	852
2024 Q3	$34K	Buy	6,842 +273	+4%	+$1.43K	0.02%	1018
2024 Q2	$34K	Buy	6,569 +2,786	+74%	+$16.5K	0.02%	1007
2024 Q1	$20K	Sell	3,783 -2,960	-44%	-$21.2K	0.01%	1217
2023 Q4	$41K	Sell	6,743 -534	-7%	-$3.71K	0.03%	938
2023 Q3	$55K	Buy	7,277 +42	+0.6%	+$384	0.04%	731
2023 Q2	$70K	Buy	7,235 +4,396	+155%	+$26.8K	0.05%	634
2023 Q1	$11K	Buy	+2,839	New	+$15.8K	0.01%	1270

Other funds holding LFCR

CWC Advisors Lake Oswego, Oregon $215M AUM 18.92% 1-Year Est. Return

MAA

Mraz Amerine & Associates Modesto, California $640M AUM 12.53% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Ulland Investment Advisors Minneapolis, Minnesota $142M AUM 22.97% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Covestor's LFCR Position: Q3 2026 in Review

Covestor increased its Lifecore Biomedical (LFCR) stake by 20% in Q3 2026, buying an estimated $7.64K and bringing the position to 9,961 shares worth $66K. The position accounts for 0.04% of the portfolio, ranked #593.

Covestor first reported a position in LFCR in Q1 2023 and has held it in 15 quarters since. The position peaked at $70K in Q2 2023. 18 funds tracked by Wall St. Rank hold LFCR as of Q3 2026.

Covestor held 9,961 shares of Lifecore Biomedical worth $66K as of Q3 2026.
Covestor bought 1,648 Lifecore Biomedical shares in Q3 2026, an estimated $7.64K.
Lifecore Biomedical made up 0.04% of Covestor's portfolio in Q3 2026, its #593 holding.
Covestor first reported a position in Lifecore Biomedical in Q1 2023 and has held it in 15 quarters since.
Covestor's Lifecore Biomedical position peaked at $70K in Q2 2023.
18 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.